Listen Now
Topics Covered
- Overview of Chronic Myelogenous Leukemia (CML)
- Current Standard of Care, New Treatment Approaches & Clinical Trials
- Managing Post Treatment Side Effects/Late Effects
- Adherence: Taking Your Pills on Schedule
- The Importance of Treatment Summaries
- Benefits of Follow-Up Care
- The Importance of Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College
Neil P. Shah, MD, PhD
Edward S. Ageno Distinguished Professor in Hematology/Oncology, Director, UCSF Molecular Medicine Residency Program, Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Carolyn Messner, DSW, OSW-C, FAPOS
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
(65.3 KB)
Workshop Date
This workshop was originally recorded on June 26, 2018.